Adma Biologics (ADMA) Receivables - Other (2016 - 2018)
Adma Biologics' (ADMA) quarterly Receivables - Other came in at $961145.0 in Q4 2018, down 22.84% YoY from $1.2 million in Q4 2017, and down 4.46% on a QoQ basis from $1.0 million in Q3 2018.
Adma Biologics (ADMA) Receivables - Other (2016 - 2018) Analysis & Trends
Adma Biologics (ADMA) has 3 years of Receivables - Other data on file, last reported at $961145.0 in Q4 2018.
- Quarterly Receivables - Other fell 22.84% year-over-year to $961145.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $961145.0 (down 22.84% YoY) and the FY2018 annual result came in at $961145.0, down 22.84% from the prior year.
- Receivables - Other declined to $961145.0 in Q4 2018, from $1.0 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.2 million in Q4 2017 to a low of $726409.0 in Q1 2018.
- A 3-year average of $1.0 million and a median of $987823.0 in 2016 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2017 — Receivables - Other grew 28.46% — and 2018, when it slipped 22.84%.
- Tracing ADMA's Receivables - Other over 3 years: stood at $969675.0 in 2016, then gained by 28.46% to $1.2 million in 2017, then fell by 22.84% to $961145.0 in 2018.
- The last three Receivables - Other figures came in at $961145.0 (Q4 2018), $1.0 million (Q3 2018), and $1.0 million (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 961,145.00 |
| Dec 31, 2018 | 961,145.00 |
| Sep 30, 2018 | 1.01 Mn |
| Sep 30, 2018 | 1.01 Mn |
| Jun 30, 2018 | 1.05 Mn |
| Jun 30, 2018 | 1.05 Mn |
| Mar 31, 2018 | 726,409.00 |
| Mar 31, 2018 | 726,409.00 |
| Dec 31, 2017 | 1.25 Mn |
| Dec 31, 2017 | 1.25 Mn |
| Sep 30, 2017 | 876,551.00 |
| Sep 30, 2017 | 876,551.00 |
| Jun 30, 2017 | 1.21 Mn |
| Jun 30, 2017 | 1.21 Mn |
| Dec 31, 2016 | 969,675.00 |
| Dec 31, 2016 | 969,675.00 |